FDA 483 OBSERVATION · #44 OF 1,923 MOST-CITED

Verification activity before import, periodically

FDA cited this observation 535 times across 484 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Foods518
Veterinary Medicine17
BY FISCAL YEAR
FY202684
FY202595
FY202488
FY2023124
FY202294
FY202133
FY202011
FY20192
FY20183
FY20171

What this observation means, and how to comply

SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.

21 CFR 1.506(e) (FSVP)

The FSVP importer did not conduct supplier-verification activities before importing and periodically thereafter, so the timing of verification did not meet the program’s requirements.

Why FDA writes it — Verification has to happen at the right time to be meaningful — before reliance on the supplier and then on an ongoing basis. Verification that never occurs, or lapses after the first shipment, leaves later imports unverified.

HOW TO COMPLY
  • Determine and conduct appropriate verification activities before importing the food and periodically thereafter.
  • Set the frequency from the risk evaluation, tightening it for higher-severity hazards.
  • Document the timing and outcome of each verification activity.
  • Trigger additional verification when performance or hazard information changes.
WHY FIRMS GET CITED
  • Verification performed once at onboarding and never repeated periodically.
  • No defined periodicity tied to the hazard’s risk.
PROFESSIONAL · REMEDIATION PLAYBOOK · SPEQ SYNTHESIS

How to close this finding — and stop it recurring

CHECKING ACCESS

Checking your Professional access…

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 2.3× the rate of the average FDA-cited firm (18.0% vs 7.8%), across 484 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your Professional access…

How FDA worded it — real examples

You did not conduct and document or obtain documentation of one or more supplier verification activities before importing the food into the United States.

SUNSTAR67 · Cerritos, California · Foods · 2026-08-20

You did not conduct and document or obtain documentation of one or more supplier verification activities before importing the food into the United States.

DRISCOLL FOOD NJ · Wayne, New Jersey · Foods · 2026-08-20

You did not conduct and document or obtain documentation of one or more supplier verification activities periodically after importing the food into the United States.

Delicias Del Contry Usa Inc · Laredo, Texas · Foods · 2026-08-04

You did not conduct and document or obtain documentation of one or more supplier verification activities.

Jefi Enterprise USA Inc · Tustin, California · Foods · 2026-07-30

You did not conduct and document or obtain documentation of one or more supplier verification activities before importing the food into the United States.

Tang's Family Corporation · Hyattsville, Maryland · Foods · 2026-07-30

You did not conduct and document or obtain documentation of one or more supplier verification activities before importing the food into the United States.

GREEN BOY GROUP · Los Angeles, California · Foods · 2026-07-29

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry →Veterinary industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →